Non sedating antidepressants
Celexa (Citalopram hydrobromide) was approved by the FDA in July 17, 1998.Celexa is manufactured by Forest Pharmaceuticals, Inc.All selective serotonin reuptake inhibitors have the same general mechanism of action.
However, now its marketing status is "Discontinued".
Research suggests that abnormalities in neurotransmitter activity can affect mood and behavior.
Low levels of serotonin and norepinephrine have not been proven to cause depression but it is widely believed that elevation of these chemicals is associated with improvement in mood in depressed people.
This leaves more serotonin available, which enhances neurotransmission and improves mood.
SSRIs are called selective because they seem to affect serotonin significantly more than other neurotransmitters.